Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis
This study found that reducing repressor of estrogen receptor activity (REA) in both donor uterine tissue and host mice significantly worsened endometriosis progression by enhancing proliferation, vascularization, inflammation, and neuron innervation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (48)
- A Botanical Extract from Channel Flow Inhibits Cell Proliferation, Induces Apoptosis, and Suppresses CCL5 in Human Endometriotic Stromal Cells1 via openalex
- A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis via openalex
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Aromatase expression in endometriosis. via openalex
- A selective estrogen receptor-β agonist causes lesion regression in an experimentally induced model of endometriosis via openalex
- Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex
- Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis via openalex
- Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment via openalex
- Endometriosis-induced vaginal hyperalgesia in the rat: Role of the ectopic growths and their innervation via openalex
- Endometriosis: The Role of Neuroangiogenesis via openalex
- Estrogen-Induced CCN1 Is Critical for Establishment of Endometriosis-Like Lesions in Mice via openalex
- Estrogen Receptor (ER) Agonists Differentially Regulate Neuroangiogenesis in Peritoneal Endometriosis via the Repellent Factor SLIT3 via openalex
- Immunolocalization and Regulation of the Chemokine RANTES in Human Endometrial and Endometriosis Tissues and Cells via openalex
- Immunolocalization and Regulation of the Chemokine RANTES in Human Endometrial and Endometriosis Tissues and Cells<sup>1</sup> via openalex
- Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium via openalex
- Krüppel-Like Factor 9 Deficiency in Uterine Endometrial Cells Promotes Ectopic Lesion Establishment Associated With Activated Notch and Hedgehog Signaling in a Mouse Model of Endometriosis via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- Molecular Network Analysis of Endometriosis Reveals a Role for c-Jun–Regulated Macrophage Activation via openalex
- Novel Therapies Targeting Endometriosis via openalex
- Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1 via openalex
- Role of Estrogen Receptor Signaling Required for Endometriosis-Like Lesion Establishment in a Mouse Model via openalex
- Steroidogenic factor-1 and endometriosis via openalex
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis via openalex
- The epidemiology of endometriosis via openalex
- The Epidemiology of Endometriosis via openalex
- The Pains of Endometriosis via openalex
- Treatment with Bazedoxifene, a Selective Estrogen Receptor Modulator, Causes Regression of Endometriosis in a Mouse Model via openalex
- Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression via openalex
- W6822444143 via openalex
- W1987292240 via openalex
- W2000423081 via openalex
- W2004489174 via openalex
- W2012263583 via openalex
- W2013297915 via openalex
- W2067808158 via openalex
- W2101115157 via openalex
- W2102477325 via openalex
- W2105225713 via openalex
- W2108743642 via openalex
- W2110802986 via openalex
- W2113583367 via openalex
- W2121381144 via openalex
- W2123795833 via openalex
- W2142120438 via openalex
- W2154377312 via openalex
- W2418373307 via openalex
- W4211081176 via openalex
- W6656356435 via openalex
Cited by (13)
- Endometriosis and Endometriosis-Associated Tumors 2025
- Endometriosis and Endometriosis-Associated Tumors 2024
- Recent insights explaining susceptibility to endometriosis-From genetics to environment 2023
- Prohibitin2/PHB2, Transcriptionally Regulated by GABPA, Inhibits Cell Growth via PRKN/Parkin-dependent Mitophagy in Endometriosis 2023
- An Update on the Multifaceted Role of NF-kappaB in Endometriosis 2022
- Efficacy of niclosamide on the intra‐abdominal inflammatory environment in endometriosis 2021
- Endometriosis and Endometriosis-Associated Tumors 2019
- Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model 2019
- Similar evolution of pain symptoms and quality of life in women with and without endometriosis undergoing assisted reproductive technology (<scp>ART</scp>) 2018
- Animal models of endometriosis: Replicating the aetiology and symptoms of the human disorder 2018
- Progressive Fibrosis: A Progesterone- and KLF11-Mediated Sexually Dimorphic Female Response 2017
- Low Body Mass Index in Endometriosis Is Promoted by Hepatic Metabolic Gene Dysregulation in Mice1 2016
- Hormonal therapy for endometriosis: from molecular research to bedside 2016
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:33.600579+00:00